News & Blogs

Jon Decker: Why doesn’t the AARP seem to care about volatile insulin prices?

Senator Chuck Grassley (R-Iowa) recently made waves claiming that pharmacy benefit managers (PBMs) are to blame for the volatility of insulin prices.  It’s a bold statement, to be sure.  But here’s the thing: the senator is absolutely right — and PolitiFact has confirmed as much. On January 31, 2021, PolitiFact partnered with The Daily Iowan to release a fact-check on Grassley’s statement, ultimately providing the senator with its highest rating of “True” on the organization’s Truth-O-Meter™.  “With their complicated discount negotiations,” PolitiFact concludes, PBMs play a role in driving upward the cost…

Learn More

Jon Decker: Take From Retirees, Give To Big Insurance: Has AARP Sold Out Its Members Like Robinhood Did?

Robinhood was once a symbol of the Everyman’s triumph over brokerage fees, capital requirements, and other barriers that had locked potential retail investors out of the stock market. The company’s innovative investing platform represented a victory for democratizing finance. But through the firm’s ongoing GameStop scandal, that perception has changed. The controversy has shaken many individuals’ faith in their company. Now, people are understandably asking: Are organizations that purport to represent everyday people actually beholden…

Learn More

Jon Decker: AARP’s Unholy Alliance With Big Insurance

A lawsuit currently being pursued by Ohio Attorney General David Yost against OptumRx, a pharmacy benefit manager (PBM), alleges that the company bilked Ohio state coffers of more than $1.3 million on generic medications. If true, taxpayers and patients should be outraged. But this is far from the only reason to distrust PBMs. PBMs are the corporate middlemen that drive the costs of drugs up for patients in pursuit of their own profits. Seniors, in particular, who…

Learn More

Jon Decker: For Real Healthcare Reform, Biden Should Break Up with Big Insurance

The enthusiastically socialist Jacobin magazine recently took President Biden to task for a healthcare plan that superficially appeared “lifted” from insurance industry lobbyists. Of course, cribbing material is nothing new for Joe Biden—and neither is going to bat for Big Insurance at the expense of Americans. Jacobin reports, “Biden’s plan would shovel billions of dollars to private health insurers by providing subsidies for Americans to buy coverage through the Affordable Care Act (ACA) marketplaces… Those initiatives — which could further boost insurers’ skyrocketing profits — were…

Learn More

Jon Decker: AARP’s Stance on Prescription Price Controls Hurts Older Americans

After the U.S. Department of Health and Human Services (HHS) recently unveiled its finalized proposal to lower prescription drug costs by passing on rebate discounts directly to Medicare patients, seniors would rightly expect the AARP to be supportive. After all, the organization is supposed to represent seniors and their interests. According to the HHS, under the current rebate system: “Drug companies pay rebates and other payments to PBMs [pharmacy benefits managers], but these payments are…

Learn More

Is AARP the Organization It Claims to Be?

During the 2020 election, AARP staff repeatedly claimed that their organization “maintains a nonpartisan stance” and “is a powerful voice for the issues and concerns of the 50 plus.” It’s true that the AARP doesn’t make political contributions or endorse candidates, as doing so would jeopardize its “non-profit” status. However, the claim that the organization is focused on issues that benefit its members is laughably wrong. Instead, the driving factor behind the political fights that…

Learn More

Why Does AARP Oppose Prescription Drug Rebate Policy that Benefits Seniors?

After the U.S. Department of Health and Human Services (HHS) recently unveiled its finalized proposal to lower prescription drug costs by passing on rebate discounts directly to Medicare patients, seniors would rightly expect the AARP to be supportive. After all, the organization is supposed to represent seniors and their interests. But that’s not what happened. Instead, it took AARP mere hours to publicly criticize the proposal, saying in part that, “AARP supports solutions that will lower drug…

Learn More

Foreign Price Controls Will Hurt Seniors

Washington politicians and bureaucrats on both sides of the aisle have recently proposed misguided policies that would impose foreign price controls on medicines in the U.S. These proposals would arbitrarily fix the cost of medications that American seniors rely on to prices set by bureaucrats in other countries with socialized health care systems. Throughout history and around the world, price controls have consistently had disastrous consequences. Especially for seniors, price controls will reduce access to…

Learn More